|
| View:
Latest News | Top Stories |
|
| 1.
|
CORRECTING and REPLACING Progenics Announces Third Quarter 2009 Financial Results
-
Business Wire
-
2 hours, 47 minutes ago
TARRYTOWN, N.Y.----In the October Highlights section, the third sentence in the second bullet should read xxx Significantly more patients on study drug experienced laxation within two and four hours compared to those on placebo . (sted xxx Significantly more patients on study drug experienced laxation within two and four hours compared to those on placebo ).
|
|
| 2.
|
Enzon Announces Agreement to Sell Specialty Pharmaceutical Business
-
Business Wire
-
Mon 8:30 am ET
BRIDGEWATER, N.J.----Enzon Pharmaceuticals, Inc. today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones.
|
|
| 3.
|
CytRx Reports 2009 Third Quarter Financial Results
-
Business Wire
-
Mon 8:30 am ET
LOS ANGELES----CytRx Corporation , a biopharmaceutical company, today reported financial results for the three months and nine months ended September 30, 2009.
|
|
| 4.
|
D.C. Vaccine Conference Attracts Government Policy Makers and Biotech Innovators
-
Business Wire
-
Mon 8:26 am ET
LOS ANGELES----BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, reports that On Monday and Tuesday of this week, the 7th Annual Vaccines: All Things Considered Conference is taking place in Washington, DC.
|
|
| 5.
|
Certain Senesco Insiders to Purchase Senesco Securities Held by Stanford Venture Capital Holdings and by Stanford International Bank
-
PR Newswire
-
Mon 8:00 am ET
Senesco Technologies, Inc. reported today that certain insiders of Senesco Technologies, Inc., a Delaware corporation , have entered into definitive stock purchase agreements to purchase all of the convertible debentures, warrants and common stock of the Company which are held by Stanford Venture Capital Holdings, Inc. and/or Stanford International Bank, Ltd. .
|
|
| 6.
|
Clinical Data, Inc. Reports Second Quarter Fiscal 2010 Results
-
Business Wire
-
Mon 7:38 am ET
NEWTON, Mass.----Clinical Data, Inc. today announced the Company’s operational and financial results for its second fiscal quarter ended September 30, 2009.
|
|
| 7.
|
Cytori Reports 3rd Quarter 2009 Financial Results
-
Business Wire
-
Mon 7:00 am ET
SAN DIEGO----Cytori Therapeutics is reporting its financial results for the quarter and nine months ended September 30, 2009. More information on commercial and clinical progress is posted online in the ‘Q3 Shareholder Letter’ at http://ir.cytoritx.com.
|
|
| 8.
|
GTx, Inc. Reports Third Quarter 2009 Corporate Results
-
Business Wire
-
Mon 7:00 am ET
MEMPHIS, Tenn.----GTx, Inc. today reported financial results for the third quarter of 2009. The net loss for the third quarter and nine months ended September 30, 2009 was $12.8 million and $35.4 million, respectively, compared with a net loss of $11.9 million and $37.9 million for the same periods in 2008.
|
|
| 9.
|
Compugen Announces Discovery of Genetic Biomarker for Predisposition to Type 2 Diabetes
-
Business Wire
-
Mon 7:00 am ET
TEL AVIV, Israel----Compugen Ltd. announced today the discovery and experimental confirmation of a genetic biomarker, CGEN-40001 for predisposition to type 2 diabetes, the most common form of diabetes.
|
|
| 10.
|
Repros Therapeutics Inc. Reports Third Quarter 2009 Financial Results
-
Business Wire
-
Mon 6:00 am ET
THE WOODLANDS, Texas----Repros Therapeutics today announced financial results for the third quarter ended September 30, 2009.
|
|
